Search results for: 'BTLA'

BTLA Screening Services B and T Lymphocyte Attenuator, or BTLA, is a human protein which inhibits T cell activation. BTLA is expressed by cytotoxic T cells (CTL), which are T lymphocytes that are able to kill foreign pathogens, viral-infected cells, and cancer cells. BTLA binding to its ligand, herpesvirus entry mediator (HVEM), results in inhibition of CTL activation. Certain cancers are able to evade the immune system by taking advantage of this inhibitory pathway.   In th...

HVEM, LIGHT & BTLA: New Immunotherapy Target The checkpoint receptors  HVEM ,  LIGHT ,  CD160 , and  BTLA  are part of a complex network of overlapping receptor interactions that function in both immune stimulation and suppression 1 ,  2  .  This regulatory function has made them therapeutic targets for treatment of cancer, autoimmune diseases and allergies, and for improved methods of organ transplants.  While presenting opportunities for...

Immunotherapy Biochemical Screening Services Immunotherapy is a type of medical treatment that engages the body's immune system to fight diseases, such as cancer, infections, and autoimmune disorders. It works by either stimulating the immune system to attack cancer cells or other disease-causing agents, or by using synthetic proteins or antibodies to target specific molecules on the surface of cancer cells or other pathogens. Immunotherapy has shown prom...

Immune Checkpoint Molecules Immune checkpoint molecules are crucial components of the immune system that regulate the intensity and duration of immune responses but have been usurped by cancer cells and pathogens to evade the immune system. Immune checkpoint molecules are crucial components of the immune system that regulate the intensity and duration of immune responses but have been usurped by cancer cells and pathogens...

Technical Notes and Application Notes Immunotherapy | Cancer Targets | CAR-T/NK Cell Therapy | Gene & Cell Therapy | Cell Culture | Cancer Pathways | CRISPR/Cas9 | Cell Receptor Targets | Ubiquitination | Protein Conjugation | Technology | Cholesterol Pathways | SARS-CoV-2/COVID-19 Immunotherapy A2aR & Immunotherapy BCMA & Cancer Bispecific Antibodies Combination Therapies for Targetin...

Combining Therapies for Targeting Immune Checkpoints   |  IMMUNE CHECKPOINTS  |           |  KINASES  |                |  PARPS  |              |  HDACS  |               |  CAR T-CELL THERAPY  | Cancer is a balance between the defens...

Citations   This page contains a list of scientific journal articles that have cited BPS products and services since 2013. We would like to congratulate all our loyal customers on their contributions to the scientific community. Our customers are truly amazing and dedicated scientists and this is evidenced by the outstanding research they are doing.  Search By Product Name or Catalog Number Name Title 10X HAT Assay Buffer (50095...